125 related articles for article (PubMed ID: 11435310)
1. Mitochondrial membrane sensitivity to depolarization in acute myeloblastic leukemia is associated with spontaneous in vitro apoptosis, wild-type TP53, and vicinal thiol/disulfide status.
Pallis M; Grundy M; Turzanski J; Kofler R; Russell N
Blood; 2001 Jul; 98(2):405-13. PubMed ID: 11435310
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 inhibits apoptosis induced by mitochondrial uncoupling but does not prevent mitochondrial transmembrane depolarization.
Armstrong JS; Steinauer KK; French J; Killoran PL; Walleczek J; Kochanski J; Knox SJ
Exp Cell Res; 2001 Jan; 262(2):170-9. PubMed ID: 11139341
[TBL] [Abstract][Full Text] [Related]
3. Differential induction of apoptosis and MAP kinase signaling by mitochondrial toxicants in drug-sensitive compared to drug-resistant B-lineage lymphoid cell lines.
O'Brien KA; Muscarella DE; Bloom SE
Toxicol Appl Pharmacol; 2001 Aug; 174(3):245-56. PubMed ID: 11485385
[TBL] [Abstract][Full Text] [Related]
4. Bcl-2 inhibitors sensitize tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by uncoupling of mitochondrial respiration in human leukemic CEM cells.
Hao JH; Yu M; Liu FT; Newland AC; Jia L
Cancer Res; 2004 May; 64(10):3607-16. PubMed ID: 15150119
[TBL] [Abstract][Full Text] [Related]
5. Redox regulation of apoptosis: impact of thiol oxidation status on mitochondrial function.
Marchetti P; Decaudin D; Macho A; Zamzami N; Hirsch T; Susin SA; Kroemer G
Eur J Immunol; 1997 Jan; 27(1):289-96. PubMed ID: 9022031
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics.
Wuchter C; Karawajew L; Ruppert V; Büchner T; Schoch C; Haferlach T; Ratei R; Dörken B; Ludwig WD
Leukemia; 1999 Dec; 13(12):1943-53. PubMed ID: 10602414
[TBL] [Abstract][Full Text] [Related]
7. The thiol crosslinking agent diamide overcomes the apoptosis-inhibitory effect of Bcl-2 by enforcing mitochondrial permeability transition.
Zamzami N; Marzo I; Susin SA; Brenner C; Larochette N; Marchetti P; Reed J; Kofler R; Kroemer G
Oncogene; 1998 Feb; 16(8):1055-63. PubMed ID: 9519879
[TBL] [Abstract][Full Text] [Related]
8. Staining of mitochondrial membranes with 10-nonyl acridine orange, MitoFluor Green, and MitoTracker Green is affected by mitochondrial membrane potential altering drugs.
Keij JF; Bell-Prince C; Steinkamp JA
Cytometry; 2000 Mar; 39(3):203-10. PubMed ID: 10685077
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial membrane potential monitored by JC-1 dye.
Reers M; Smiley ST; Mottola-Hartshorn C; Chen A; Lin M; Chen LB
Methods Enzymol; 1995; 260():406-17. PubMed ID: 8592463
[No Abstract] [Full Text] [Related]
10. Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML).
Del Poeta G; Venditti A; Del Principe MI; Maurillo L; Buccisano F; Tamburini A; Cox MC; Franchi A; Bruno A; Mazzone C; Panetta P; Suppo G; Masi M; Amadori S
Blood; 2003 Mar; 101(6):2125-31. PubMed ID: 12424199
[TBL] [Abstract][Full Text] [Related]
11. Subcellular distribution and redistribution of Bcl-2 family proteins in human leukemia cells undergoing apoptosis.
Jia L; Macey MG; Yin Y; Newland AC; Kelsey SM
Blood; 1999 Apr; 93(7):2353-9. PubMed ID: 10090946
[TBL] [Abstract][Full Text] [Related]
12. Rapid collapse of mitochondrial transmembrane potential in HL-60 cells and isolated mitochondria treated with anti-tumor 1,4-anthracenediones.
Wang Y; Perchellet EM; Ward MM; Lou K; Hua DH; Perchellet JP
Anticancer Drugs; 2005 Oct; 16(9):953-67. PubMed ID: 16162972
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of autophagy as a treatment strategy for p53 wild-type acute myeloid leukemia.
Folkerts H; Hilgendorf S; Wierenga ATJ; Jaques J; Mulder AB; Coffer PJ; Schuringa JJ; Vellenga E
Cell Death Dis; 2017 Jul; 8(7):e2927. PubMed ID: 28703806
[TBL] [Abstract][Full Text] [Related]
14. Effects of secretagogues and bile acids on mitochondrial membrane potential of pancreatic acinar cells: comparison of different modes of evaluating DeltaPsim.
Voronina SG; Barrow SL; Gerasimenko OV; Petersen OH; Tepikin AV
J Biol Chem; 2004 Jun; 279(26):27327-38. PubMed ID: 15084611
[TBL] [Abstract][Full Text] [Related]
15. Apoptotic response to homoharringtonine in human wt p53 leukemic cells is independent of reactive oxygen species generation and implicates Bax translocation, mitochondrial cytochrome c release and caspase activation.
Cai Z; Lin M; Wuchter C; Ruppert V; Dörken B; Ludwig WD; Karawajew L
Leukemia; 2001 Apr; 15(4):567-74. PubMed ID: 11368358
[TBL] [Abstract][Full Text] [Related]
16. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
[TBL] [Abstract][Full Text] [Related]
17. Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis.
Costantini P; Belzacq AS; Vieira HL; Larochette N; de Pablo MA; Zamzami N; Susin SA; Brenner C; Kroemer G
Oncogene; 2000 Jan; 19(2):307-14. PubMed ID: 10645010
[TBL] [Abstract][Full Text] [Related]
18. Flt3 Y591 duplication and Bcl-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53.
Irish JM; Anensen N; Hovland R; Skavland J; Børresen-Dale AL; Bruserud O; Nolan GP; Gjertsen BT
Blood; 2007 Mar; 109(6):2589-96. PubMed ID: 17105820
[TBL] [Abstract][Full Text] [Related]
19. Impact of the expression of P glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat shock protein 27 on response to induction therapy and long-term survival in patients with de novo acute myeloid leukemia.
Kasimir-Bauer S; Beelen D; Flasshove M; Noppeney R; Seeber S; Scheulen ME
Exp Hematol; 2002 Nov; 30(11):1302-8. PubMed ID: 12423683
[TBL] [Abstract][Full Text] [Related]
20. Two distinct modes of oncoprotein expression during apoptosis resistance in vincristine and daunorubicin multidrug-resistant HL60 cells.
Belhoussine R; Morjani H; Gillet R; Palissot V; Manfait M
Adv Exp Med Biol; 1999; 457():365-81. PubMed ID: 10500812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
